What DaVinci does

DaVinci (operating as DaVinci Biomedical Research) is a private, for-profit preclinical contract research organization (CRO) founded in 1993 and headquartered in Central Massachusetts. The company operates a 67,000+ sq ft state-of-the-art, AAALAC-accredited facility and provides both GLP and non-GLP in vivo preclinical testing services to sponsors in the medical device, pharmaceutical, biotechnology, gene therapy, and regenerative medicine sectors. Core service offerings include telemetry, biomechanical testing, custom model development, and pre-instrumentation of animal models — capabilities typically required for IND- and IDE-enabling safety, efficacy, and feasibility studies.

Underlying technical capabilities center on surgical execution and vivarium-based in vivo study execution, with AAALAC accreditation and GLP compliance serving as regulatory-grade quality infrastructure that sponsors require for regulatory submission data. The company's business model is fee-for-service CRO work, monetizing through study-based contracts where pricing scales with model complexity, study duration, GLP vs. non-GLP tier, telemetry/biomechanical instrumentation, and custom model development scope. Customer segments span medtech, pharma, biotech, and advanced therapy sponsors, giving the company diversified exposure across preclinical end-markets rather than dependency on a single sponsor type.

The 30+ year operating history and breadth of vertical coverage suggest an established niche CRO with multi-decadal sponsor relationships, though the publicly available material is thin on recent capacity additions, hiring signals, or technology investments that would indicate the company's current operating momentum.

Name

DaVinci

Legal name

DaVINCI Biomedical Research

Website

https://davincibiomed.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

DaVinci Biomedical Research is a Central Massachusetts-based preclinical CRO operating a 67,000+ sq ft AAALAC-accredited facility, delivering GLP and non-GLP in vivo testing, telemetry, biomechanical, and custom model development services to medical device, pharma, biotech, gene therapy, and regenerative medicine sponsors.

Ownership category

akta.pro rank

Headquarters

HQ city

Charlotte

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Preclinical Contract Research Services: Contract research organization (CRO) providing fee-for-service preclinical testing including GLP studies for FDA submissions, non-GLP developmental studies, acute and chronic testing across multiple therapeutic areas. Revenue generated through project-based contracts for medical device testing, pharmaceutical research, gene therapy validation, and regenerative medicine studies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

DaVINCI Biomedical Research is a preclinical Contract Research Organization (CRO) providing GLP and non-GLP in vivo animal testing services for medical device, pharmaceutical, biotechnology, gene therapy, and regenerative medicine companies. Core offerings include customized preclinical model development, pre-instrumentation of models, in vivo surgical testing, biocompatibility/toxicology/pyrogenicity evaluations, and efficacy and safety studies that support FDA regulatory submissions (510K and IND). All services are delivered from an AAALAC-accredited, 67,000+ sq. ft. facility in Central Massachusetts.

Product overview

DaVINCI Biomedical Research is a premier preclinical CRO offering a unified platform of integrated testing services. The portfolio centers on GLP and non-GLP preclinical testing services for medical devices, pharmaceuticals, biotechnology, and gene therapy sectors. Core offerings include In Vivo Testing with specialized surgical models, Medical Device Testing with telemetry and biomechanical capabilities, Pharmaceutical Research covering pharmacokinetics and toxicology, Gene Therapy Solutions, Biotechnology Research Services, and Regenerative Medicine studies. All services support FDA regulatory submissions (510K, IND) and span therapeutic areas including cardiovascular, neurological, orthopedic, gastrointestinal, and wound healing applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Preclinical Testing Services Premier preclinical CRO offering GLP and non-GLP animal studies for medical devices, pharmaceuticals, biotechnology, and gene therapy applications. Services include biocompatibility testing, toxicology, pyrogenicity, safety and efficacy studies, and acute-chronic testing.
• In Vivo Testing In vivo animal model testing services with specialized surgical expertise for cardiovascular, neurological, orthopedic, gastrointestinal, and other applications, supporting acute and chronic study designs.
• GLP Studies for FDA Submission Good Laboratory Practice compliant studies designed for FDA regulatory submissions including 510K, IND, safety, efficacy, and biocompatibility evaluations.
• Non-GLP Developmental Studies Flexible non-GLP research studies for drug and device development at various stages of the research pipeline.
• Medical Device Testing Comprehensive medical device preclinical testing including cardiovascular, endovascular, neurological, orthopedic, gastrointestinal, wound healing, meshes, and coatings testing with telemetry solutions and biomechanical testing capabilities.
• Biotechnology Research Services Preclinical research services supporting biotech companies with precision and scientific rigor for groundbreaking discoveries across multiple disciplines including siRNA, Engineered Cells, Small Molecule, Nano Treatments, Bio-printed and Bio-generated Materials, and Engineered Tissues.
• Gene Therapy Solutions Expertise in gene therapy research including cellular, vectors (bacterial and viral), nanoparticles, and gene editing applications.
• Pharmaceutical Research Pharmaceutical testing services covering pharmacokinetics, toxicokinetic, biodistribution, PK characterization, metabolization, and interspecies scaling across multiple disciplines.
• Regenerative Medicine Regenerative medicine research including organ scaffold and cell-based solutions, cardiovascular medicine, orthopedics, urology, organ/tissue transplant, soft and connective tissue therapies, wound healing, and bone regeneration.

Quantifiable outcome

• Reliable and reproducible results for safety and efficacy studies

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DaVinci